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This study aimed to evaluate the tumorigenic potential of functionalising poly(LLA-co-CL) scaffolds. The
copolymer scaffolds were functionalised with nanodiamonds (nDP) or with nDP and physisorbed BMP-2
(nDP-PHY) to enhance osteoinductivity. Culturing early neoplastic dysplastic keratinocytes (DOKLuc) on
nDP modiﬁed scaffolds reduced signiﬁcantly their subsequent sphere formation ability and decreased
signiﬁcantly the cells' proliferation in the supra-basal layers of in vitro 3D oral neoplastic mucosa (3D-OT)
when compared to DOKLuc previously cultured on nDP-PHY scaffolds. Using an in vivo non-invasive
environmentally-induced oral carcinogenesis model, nDP scaffolds were observed to reduce biolumi-
nescence intensity of tumours formed by DOKLuc þ carcinoma associated ﬁbroblasts (CAF). nDP modi-
ﬁcation was also found to promote differentiation of DOKLuc both in vitro in 3D-OT and in vivo in
xenografts formed by DOKLuc alone. The nDP-PHY scaffold had the highest number of invasive tumours
formed by DOKLuc þ CAF outside the scaffold area compared to the nDP and control scaffolds. In
conclusion, in vitro and in vivo results presented here demonstrate that nDP modiﬁed copolymer scaf-
folds are able to decrease the tumorigenic potential of DOKLuc, while conﬁrming concerns for the ther-
apeutic use of BMP-2 for reconstruction of bone defects in oral cancer patients due to its tumour
promoting capabilities.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).logy, Department of Clinical
of Bergen, N-5021, Bergen,
logy, Department of Clinical
of Bergen, N-5021, Bergen,
man), daniela.costea@uib.no
Ltd. This is an open access article u1. Introduction
Extensive efforts have been made in bone tissue engineering
(BTE) to combine osteogenic growth factors with scaffolds in order
to control their release, thus regenerating bone defects with min-
imal side effects [1]. Bone morphogenetic proteins (BMPs) are
members of the large TGF-b superfamily, which play a crucial role
in regulating cell proliferation, apoptosis, differentiation andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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an absorbable collagen sponge were carried out in several ortho-
paedic approaches. These ranged from spinal fusions to long bone
fractures and more recently augmenting the alveolar ridge, cleft
reconstructions and sinus lift surgeries [3e5]. The use of BMP-2
was reported advantageous over the ‘gold standard’, autologous
bone graft, by shortening the operating time and decreasing hos-
pitalisation costs. However, its off-label use even in oral and
maxillofacial surgeries came with several side effects [6e8]. Those
side effects were attributed to uncontrolled release of high doses of
the embedded growth factor. Cancer has been an alarming adverse
effect reported by studies on spinal surgeries using BMP-2, while
some studies showed a link between use of BMP-2 and carcino-
genesis; others did not ﬁnd this association [9,10]. Nevertheless, the
observed increase in cancer incidence, while low and uncertain,
remains a real concern for the use of recombinant BMP-2 (rhBMP-
2). In addition, several studies expressed concern and had impli-
cations for the safe delivery of BMP-2 when reconstructing bone
defects after extensive surgeries for treating oral squamous cell
carcinomas (OSCC) [11,12]. In vitro and in vivo investigations of the
effects of BMP-2 on OSCC cells showed an increase in the invasive
potential and poor survival rate after exposure to BMP-2 [11,12].
Moreover, this association was also observed for gastric and breast
cancer cells [13]. The association between BMP-2 and OSCC was
also indicated from patient studies. In a cohort of 149 patients with
oral, head and neck squamous cell carcinoma analysed retrospec-
tively; tumours with higher BMP-2 expression were found to have
higher rates of local failure and local recurrence [14]. In normal
human keratinocytes in vitro, BMP-2 was shown to modulate the
expression of molecules related to Wnt signalling which may be
affected by the fate of keratinocytes, such as their proliferation,
migration and differentiation [15]. Also, epithelial to mesenchymal
transition in human skin would healing was shown to be modu-
lated by BMP-2 in human normal keratinocytes in vitro [16].
Nanodiamond (nDP), a carbon derived nanoparticle of about
4e5 nm in diameter with low chemical reactivity and unique
physical properties [17,18] have emerged as potentially useful ma-
terials in bone regeneration. As a stable colloid, they were used to
deliver osteogenic molecules such as BMP-2 for promoting bone
formation [19]. Cell viability assays showed that nDP are not toxic to
a variety of cell types [20]. They have been tested for their cyto-
toxicity in suspensions and it was reported that higher concentra-
tions affect cell proliferation and metabolic activities in
macrophages [21]. Nano-sized materials demonstrated controver-
sial results during long term implantations in murine models [22],
but assessment of carcinogenicity of nDP is an unexplored area,
especially in the context of biomaterial modiﬁcations.
Aliphatic polymers have been commonly used in the biomedical
ﬁeld and also approved by the Food and Drug Administration in
several clinical products [23]. Copolymer scaffolds synthesised
from L-lactide (LLA) and ε-caprolactone (ε-CL), (poly[LLA-co-CL]),
have been comprehensively validated as BTE scaffolds with
encouraging cyto-compatibility and osteoconductivtiy outcomes
both in vitro and in vivo [24e26]. Modifying these copolymer
scaffolds with nDP improved their mechanical properties and
enhanced their wettability which positively affected their osteo-
conductive potential [27,28]. A modality of delivering BMP-2 to
bone defects using poly(LLA-co-CL) scaffolds modiﬁed with nDP
was recently developed in an attempt to reduce side effects from
conventional high dose burst delivery. It proved successful phys-
isorption of BMP-2 onto the nDP; sustained low amounts of
bioactive BMP-2 released up to 70 days, and enhanced osteogenic
differentiation of human mesenchymal stem cells, in addition to
accelerated bone formation in a rat mandible critical-sized defect
[29]. This construct carries two stimulating factors, nanodiamondparticles and BMP-2, which makes a testing of its biocompatibility
on one hand side and long term adverse effects on the other hand
crucial. Biomaterials implanted, such as those for the purpose of
tissue regeneration have been reported on their potential of
inducing foreign body carcinogenesis and are usually tested in long
term 2 year rodent assays or half a year in transgenic mice [30].
Although this phenomenon is rarely encountered in humans [31], it
cannot be overlooked and every new biomaterial is required to
rigorously undergo adverse effect testing for regulatory reasons
[32].
An in vivo environmentally-induced oral carcinogenesis model
to screen the tumorigenic potential of BTE scaffolds has been
recently reported by our research group to successfully and reliably
monitor the scaffolds by bioluminescence (BLI) in an attempt to
surpass the limitations of the long term rodent assays [33]. The
model has been developed using early neoplastic dysplastic oral
keratinocytes (DOK) and the poly(LLA-co-CL) scaffolds. The DOK
are derived from a tongue dysplasia (premalignant oral mucosa
lesion) that progressed after 11 years into a well-differentiated
OSCC [34]. They were reported to be partly transformed but non-
tumorigenic in NUDE mice and our previous research on non-
obese diabetic/severe combined immunodeﬁcient (NOD/SCID)
mice showed that DOK at a low density were tumorigenic only
when co-inoculated with carcinoma associated ﬁbroblasts (CAF)
[35]. The use of dysplastic cells instead of normal keratinocytes was
carried to gain advantage over the time spent to reproduce muta-
genic events in tumour models with experimental setting from
normal cells [36]. We therefore chose to use the early neoplastic
cells, DOK, as a screening tool to evaluate the tumour promoting
potential of scaffolds, providing a faster alternative to the long ‘life-
time’ in vivo models [33].
In this current investigation the developed model was used
along with several in vitro functional tumorigenicity assays to
evaluate the effect of functionalising poly(LLA-co-CL) scaffolds with
nDP or with nDP and physisorbed BMP-2.
The authors postulate that the functionalised poly(LLA-co-CL)
scaffolds with nDP will have an effect on the differentiation of
DOK owing to nDP's inherent functional groups that were shown to
enhance the differentiation of other type of cells [28].
2. Materials and methods
2.1. Scaffold fabrication and modiﬁcation with nDP and
nDP þ BMP-2
Poly(LLA-co-CL) was synthesised from 75 mol % L-lactide and
25 mol % ε-caprolactone as previously described [26,37] conﬁrmed
by proton nuclear magnetic resonance (Bruker Avance 400, Bill-
erica, MA, USA). The puriﬁed copolymer had a number average
molecular weight of z100,000 Da and a molar mass dispersity
z1.3 determined by size exclusion chromatography (Polymer
Laboratories, U.K.). The porous poly(LLA-co-CL) scaffolds were
prepared by solvent casting particulate leaching and a disc-shaped
scaffold (diameter z 12 mm/thickness z 1.3 mm) for in vitro ex-
periments and (diameterz 6 mm/thicknessz 1.3 mm) for in vivo
experiments [26]. Porosity was >83%measured bymicro computed
tomography, (Skyscan 1172, Bruker) (40 kV and 2.4 mm voxel).
Detonation diamond puriﬁed by acid (Gansu Lingyun Corp.,
Lanzhou, China) was milled for dispersion using a method previ-
ously described [38] producing a narrow size distribution at ~5 nm
particle diameter (measured by dynamic light scattering in water)
and low agglomeration of the diamond particles. Brieﬂy, scaffolds
were modiﬁed with the nDP solution (2 wt %, i.e. 20 mg/ml) by a
vacuum technique: 0.5 ml nDP solution and one scaffold were put
in a glass beaker and perfused in vacuum (Oerlikon Leybold, TRIVAC
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Recombinant BMP-2 expressed in Escherichia coli (E-coli), iso-
lated from inclusion bodies, renatured and puriﬁed and the
poly(LLA-co-CL) scaffolds were modiﬁed using the nanodiamond
particles and physisorbed with BMP-2 as previously described [29].
Each scaffold contained 1 mg of BMP-2.
Unmodiﬁed poly(LLA-co-CL) scaffolds are denoted by CL scaf-
fold, scaffolds modiﬁed with nanodiamond by nDP scaffold and
scaffolds modiﬁed with nanodiamond plus physisorbed with BMP-
2 by nDP-PHY scaffold.
2.2. Cell source and maintenance
Three different cell types were used in the in vitro and/or in vivo
experiments.
2.2.1. Early neoplastic dysplastic oral keratinocyte (DOK)
DOK cell line purchased from The European Collection of Cell
Cultures (Salisbury, Wiltshire, UK) [34] was transduced to contain
the ﬁreﬂy luciferase as described previously [33]. Brieﬂy, infectious
retroviral vector particles were produced in Phoenix A cells (LGC
Standards AB, Boras, Sweden). Transduction with a luciferase
expressing construct, L192, coding for the luciferase enzyme and
co-transduced with the tetracycline-regulated transactivator (tTA)
was carried out as previously described [39]. Cells were selected
with puromycin (1 mg/ml) (Sigma, St Louis, MO, USA). Transduced
DOK were designated as DOKLuc. They were maintained in Dul-
becco's Modiﬁed Eagle's Medium (DMEM) supplemented with 10%
Foetal Calf Serum (FCS, Invitrogen, Waltham, MA, USA), 20 mg/ml L-
glutamine, 5 mg/ml hydrocortisone (Sigma).
2.2.2. Carcinoma associated ﬁbroblasts (CAF)
CAF were isolated from histologically conﬁrmed OSCC, after
informed consent using a previously described explant technique
[40] and were cultured in FAD medium: DMEM/Ham's F12 1:3
mixture, 1% L-glutamine, 0.4 mg/ml hydrocortisone, 50 mg/ml
ascorbic acid, 10 ng/ml EGF, 5 mg/ml insulin and 20 mg/ml trans-
ferrin and linoleic acid (all from Sigma) with 10% FCS.
2.2.3. Gingival ﬁbroblasts (GF)
GF were isolated from normal human oral mucosa of individuals
undergoing third molar extraction after informed consent, using
the aforementioned explant technique and maintained in DMEM
high glucose þ 10% FCS (Sigma).
2.3. In vitro functional assays for tumorigenic properties
The CL, nDP and nDP-PHY scaffolds (n ¼ 20 per scaffold type)
were placed in 48-well plates. DOKLuc (25  104 per scaffold) were
seeded on top and allowed to culture. After 1 week the DOKLuc were
trypsinised from the scaffolds and allowed to plate and propagate
for 19 days in tissue culture ﬂasks (Nunc, ThermoScientiﬁc, Wil-
mington, Delaware, USA) to obtain sufﬁcient number of cells before
exposing them to the following functional assays.
2.3.1. Sphere formation assay
To obtain non-adherent surfaces 48-well tissue culture plates
were coated overnight with 1 ml of 12 mg/ml stock of 2-
hydroxyethyl methacrylate (Sigma) in 95% methanol. Five hun-
dred DOKLuc were mixed in 475 ml of FAD medium with 25 ml of
Matrigel (BD Biosciences, NJ, USA). The cells were allowed to grow
for 3 weeks before images (n ¼ 6 per well) were obtained of each
well and spheres larger than 40 mm in diameter were counted,
considered to include spheres formed of more than 50 cells
approximately.2.3.2. Three-dimensional organotypic cultures (3D-OT)
GF or CAF were used at early passages (less than 10) to create the
stromal compartment of the 3D-OT. The collagen matrix was pre-
pared on ice bymixing 7 vol of rat tail collagen type I (BD bioscience),
2 vol of reconstitutionbuffer (composedof 2.2 gNaHCO3, 0.6 gNaOH,
4.766 gHEPES (all fromSigma) in 100ml dH2O) to achieve a pHof 7.2
and 1 vol of DMEM 4 (Sigma). Each type of ﬁbroblast was ﬁrst re-
suspended in 1 vol of FCS in a ﬁnal concentration of
2.5  105 cells/matrix and then added to the aforementioned
mixture. Seven hundred ml of this mixture was added onto eachwell
of 24 well dishes (Nunc, Thermo Fisher Scientiﬁc, Waltham, MA,
USA). After 20min incubation at 37 C, thematrix solidiﬁed and 1ml
of routine medium for the respective ﬁbroblast type was added on
top. One day later, DOKLuc extracted from the scaffolds were re-
suspended in DOK medium and seeded on top of the collagen bio-
matrix at a concentration of 5  105 cells per matrix to re-construct
the epithelial compartment of the 3D-OT. After 2 days of co-culture,
the 3D-OTswere detached and lifted on a stainlessmetal grid to keep
them at the air liquid interface for a week in the OT medium. Two
thirds of the medium was changed every 2nd day. The OT medium
was composed of DMEM:Ham-F12 1:3 mixture, supplemented with
0.4 mg/ml hydrocortisone, 20 mg/ml transferrin, 50 mg/ml L-ascorbic
acid, 1 mg/ml linoleic acid-albumin, 20 mg/ml L-Glutamine (all from
Sigma), 5 mg/ml insulin (NovoNordisk, Bagsværd, Denmark). After 10
days of co-culture the 3D-OT were harvested and ﬁxed in 4% para-
formaldehyde (PFA) before processing for parafﬁn embedding. As a
positive control, DOKLuc routinelygrown in tissue culture plateswere
harvested and cultured on top of collagen biomatrix with CAF
instead of GF, and following the same aforementioned procedure.
Thiswas inspired from our previous researchwhich showed that the
invasion of malignant oral keratinocytes was signiﬁcantly greater
when CAF were embedded in the biomatrix compared to when
normal oral ﬁbroblasts were used [35].
2.4. Animal procedures
The different scaffolds were also evaluated for the tumorigenic
potential invivousingour recentlydevelopedmicroenvironmentally-
inducedmodel employing BLI tomonitor the tumour formation non-
invasively. NOD-scid IL2rgnull (NSG) female mice (University of Ber-
gen, Bergen, Norway) were used at 8e10 weeks old.
The scaffolds were ﬁrst pre-wet with DOKmedium before being
seededwith cells, DOKLuc alone or DOKLucþ CAFs (positive control).
Seeding density was 1  104 and 1  105 for DOKLuc and CAF
respectively. Plates were vortexed and cells allowed to attach
overnight. Subcutaneous operating procedure was performed as
previously described under Isoﬂurane gas anaesthesia, and all ef-
forts were made to minimise suffering [41]. Two scaffolds were
implanted into the back of each mouse, one scaffold with DOKLuc
alone and the other with DOKLuc þ CAF.
Optical BLI: To non-invasivelymonitor tumour formation in vivo,
mice were depilated and scanned following intraperitoneal de-
livery of 150mg/kg of D-luciferin (Biosynth, AG, Staad Switzerland).
Images were captured using In Vivo MS FX PRO (Carestream Health
Inc. Rochester, NY) and analysed using Carestream MI SE version
5.0.6.20, 1 exposure of 90 s duration. At 14 weeks animals were
euthanized (n ¼ 6 per scaffold type). Xenografts were carefully
dissected from the subcutaneous region and ﬁxed in 4% PFA before
being processed for parafﬁn embedding.
2.5. Immunohistochemistry
Parafﬁn embedded 3D-OTs and tumour xenografts were
sectioned at 3e4 mm and stained with hematoxylin-eosin (H&E)
(Sigma). Sectioned 3D-OTs were additionally stained for Ki67
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EGFR (Dako) and Involucrin (NovoCastra, Wetzlar, Germany) to
evaluate the degree of differentiation and E-Cadherin (Dako) to
evaluate the tissue coherence. The primary antibodies (Ab) and
titrations used were as follows: mouse monoclonal antibody (mAb)
Ki-67 clone MIB-11:25; mAb EGFR clone H111:50; mAb Involucrin
1:500 and mAb E-cadherin clone NCH-38 1:3000. All Ab were
diluted in antibody diluent (Dako). Sections were then counter-
stained with hematoxylin (DAKO), dehydrated and cover-slipped.
The bound reaction was visualized using 3, 30-diaminobenzidine
tetra hydrochloride (DAB, Dako). Sections of tonsils and normal oral
mucosa served as positive controls. For negative controls, sections
incubated with antibody diluent only were used.
2.6. Quantiﬁcation of staining
The depth of invasion in the 3D-OTs was evaluated on H&E
sections using a light microscope and the software Olympus DP.Soft
5.0. The central and the twoouter 5ths of 3D-OTswere excluded due
to technical variations. The depth of invasionwas determined every
100 mmas the vertical distance froman arbitrary line drawn through
the upper remnants of the collagen biomatrix and representing the
basementmembrane till the deepest limit of invading DOKLuc in the
respective ﬁeld. At least 6 measurements were taken per tissue.
Immunostained sections were imaged using a Nikon Eclipse 80i
microscope equippedwith a Nikon DS-Fi1 camera (Tokyo, Japan), to
quantify positively stained Ki67, involucrin, EGFR and E-cadherin
cells. Ki-67 positively stained nuclei were counted separately in the
basal and para-basal area and in the supra-basal area for each
sample and presented as a percentage of the total number of nuclei
in the epithelial compartment. The open source digital image
analysis software ImageJ (v.1.46r) (National Institute of Health,
USA) was used to count positively stained Ki67 nuclei. Recently
developed Plugin IHC Proﬁler compatible with ImageJ was used for
quantifying involucrin, EGFR and E-cadherin stain. An area of in-
terest was drawn around the (basal and para-basal area) and
another area of interest around the supra-basal area and each was
quantiﬁed separately. The software creates a pixel-by-pixel analysis
proﬁle of a digital immunohistochemistry image and further
scoring it using a four level system [42]. The highly positive scores
were used for each area and a ratio of supra-basal area to basal and
para-basal areas was calculated to plot quantiﬁcation graphs.
2.7. Ethical approval
The ethical approvals for sample collection from OSCC patients
and individuals undergoing third molar extraction samples were
obtained from the Regional Committee for Medical and Health
Research Ethics (REK # 2010/481). Samples were collected
following informed consent of the patients.
Animal experiments were approved by the Norwegian Animal
Research Authority and conducted in strict accordance with the
European Convention for the Protection of Vertebrates used for
Scientiﬁc Purposes (FOTS no. 20135297).
2.8. Statistical analysis
All data are presented as themean values ± standard error of the
mean (SEM). Signiﬁcant difference in the sphere formation, depth
of invasion between groups in 3D-OT and signiﬁcant difference in
immunohistochemical stain quantiﬁcation was tested by One-way
ANOVA, followed by a multiple comparison Tukey test. Paired t-
test was used to compare differences between the total photon
counts of the different tumours (DOKLuc or DOKLuc þ CAF) in each
scaffold group. SPSS ver. 21/22 (IBM, NY, USA) was used and thelevel of signiﬁcance was set to p < 0.05.
3. Results
3.1. DOKLuc cells previously cultured on nDP scaffolds showed
decreased sphere formation ability when compared to DOKLuc
previously cultured on other scaffolds
When retrieved after being seeded on different scaffolds for 1
week and further propagated in culture on adherent plates, DOKLuc
cells displayed a typical epithelial morphology for all conditions.
There was no difference in the proliferation rate of cells seeded on
the different scaffolds, but DOKLuc previously seeded on nDP scaf-
folds contained a number of cells with a larger cell surface area
when compared with cells seeded on other scaffolds (Fig. 1A, yel-
lowarrows). The DOKLuc extracted from the different scaffolds were
also subjected to non-adherent culture to evaluate their anchorage
independent growth and hence their tumorigenic potential. After
being cultured on nDP coated scaffolds, DOKLuc formed a signiﬁ-
cantly reduced number of spheres compared with the CL and nDP-
PHY scaffolds (Fig. 1 B, C).
3.2. DOKLuc previously grown on nDP scaffolds displayed a less
abnormal proliferation pattern and increased differentiating
capacities in 3D-OT models when compared with DOKLuc previously
grown on other scaffolds
The DOKLuc cells grown on nDP-PHY scaffolds and the positive
control (DOKLuc grown on CAF) showed the highest percentage of
Ki67 positive nuclei in the (basal and para-basal) layers, which was
signiﬁcantly higher for nDP-PHY modiﬁed scaffolds when
compared to the other scaffold types (Fig. 2 A). The cells from the
nDP-PHY modiﬁed scaffolds (p ¼ 0.011) and the positive control
(p ¼ 0.007) had signiﬁcantly increased expression of Ki-67 in the
supra-basal layers, compared with cells from nDP modiﬁed scaf-
folds. The cells from the nDP and CL scaffolds showed cell prolif-
eration conﬁned mainly to the basal layer.
Assessment of the epithelial differentiation marker involucrin
showed in the positive controls for stimulating the tumorigenesis
(DOKLuc on CAFs 3D-OT) a random expression throughout all
epithelial layers, without the normal polarisation of stronger
expression in the superﬁcial layers and weaker expression in the
basal/para-basal layers as found in a normal oral epithelium. The
models constructed with DOKLuc from the scaffolds showed also
involucrin expression in all epithelial layers but DOKLuc previously
grown on nDP-PHY scaffolds showed a signiﬁcantly reduced
expression of involucrin in the supra-basal layers and mostly in the
para-basal layers. This indicated an abnormal pattern of differen-
tiation, similar to the positive control for tumorigenesis. On the
contrary, involucrin was signiﬁcantly highly expressed in the upper
(supra-basal) epithelial layers of the 3D-OT formed by DOKLuc from
nDP scaffolds (Fig. 2 B), a pattern of expression closest to that found
in normal human oral mucosa. The pattern of EGFR staining in our
3D-OTs was also investigated and an opposite trend to the invo-
lucrin staining was observed in all conditions, including the posi-
tive control. However, the difference between groups was not
statistically signiﬁcant.
3.3. DOKLuc cells previously grown on nDP scaffolds displayed lower
invasive potential and increased expression of cell adhesion
molecule E-cadherin when compared to DOKLuc previously grown
on other scaffolds
DOKLuc showed the highest invasive potential (deeper invasion)
when cultured on the positive control (with CAFs in the biomatrix).
Fig. 1. Morphology and adherence-independent growth behaviour of DOKLuc after being cultured on the different scaffolds. (A) Light micrograph of the DOKLuc cultured in a
tissue culture plate and representative micrographs of DOKLuc propagated 1 week after being extracted from the different scaffolds. The cells preserved their epithelial morphology
in all conditions. A number of cells previously grown on nDP scaffold displayed abundant cytoplasm and larger surface areas (yellow arrows). (B) Average number of spheres (larger
than 40 mm in diameter) formed after 21 days in culture. (C) Representative light micrographs showing spheres formed by DOKLuc extracted from different scaffolds. Scale bar
50 mm. Error bars represent SEM. *p < 0.05, **<0.01. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
S. Suliman et al. / Biomaterials 95 (2016) 11e21 15This invasive potential was similar to that of DOKLuc previously
seeded on nDP-PHY scaffolds but cultured on normal GF in 3D-OT
(Fig. 3B). A signiﬁcant decrease in DOKLuc invasion was observed in
the 3D-OTs that were seeded with DOKLuc from nDP scaffold
(Fig. 3B). The DOKLuc grown on collagen biomatrices populated
with CAF showed an expansion of intercellular spaces along thelength of the epithelium. Further investigation of the cell adhesion
molecule E-cadherin was done in this study, promoted by the
increased spongiosis and invasion previouslymentioned to occur in
the epithelium of 3D-OTs, particularly in the positive control group.
E-cadherin showed an expression generally conﬁned to the cell
membranes of epithelium formed from DOKLuc in all groups, but
Fig. 2. Proliferating and differentiating capacities of DOKLuc after culture on the different scaffolds. (A) Percentage of Ki67 positively stained nuclei of DOKLuc in the basal and
para-basal area and in the supra-basal layers of the epithelial compartment of the 3D-OTs. (B) Quantiﬁcation of involucrin expressed as a ratio of positive cells in supra-basal area to
basal and para-basal areas of the epithelial compartment of 3D-OTs formed by DOKLuc previously grown on different scaffolds. (C) Quantiﬁcation of EGFR expressed as a ratio of
positive cells in supra-basal area to basal and para-basal areas. (D) Representative micrographs of sections stained for Ki67 (Scale bar ¼ 100 mm), involucrin (black arrows point at
normal pattern of stain in the superﬁcial layers of the epithelium) and EGFR (black arrows point at invading cells highly expressing EGFR) (Scale bar ¼ 50 mm). All are counterstained
with hematoxylin. All immunostains used DAB and the brown colour represents the positive result. Error bars represent SEM. *p < 0.05, **p < 0.01. (E) Descriptive example of how
the basal and para basal areas were differentiated. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 3. Invasive potential of DOKLuc after culture on the different scaffolds. (A)
Measuring invasion of DOKLuc in the sectioned 3D-OT every 100 mm as the vertical
distance from an arbitrary line drawn through the upper remnants of the collagen
biomatrix and representing the basement membrane till the deepest limit of invading
DOKLuc in the respective ﬁeld (red lines) (B) Quantiﬁcation of the depth of invasion of
the epithelium formed by DOKLuc cells in 3D-OTs. DOKLuc extracted from the different
scaffolds were grown on collagen matrices populated with GF. As a positive control for
a tumorigenic signal [35] DOKLuc from a monolayer were grown on a matrix populated
with CAF. DOKLuc previously grown on nDP scaffolds showed a signiﬁcantly reduced
invasion in the bio-matrix as compared to those from nDP-PHY scaffolds and cells
grown on positive control. Error bars represent SEM. *p < 0.05, **<0.01. (C) Left panel
displays representative H&E stained sections of 3D-OTs with DOKLuc previously grown
on different scaffolds and positive control (CAF) (Scale bar 100 mm). Right panel dis-
plays representative E-cadherin stained sections of 3D-OTs with DOKLuc previously
grown on different scaffolds and positive control (CAF). Scale bar 50 mm. The immu-
nostaining used DAB and the brown colour represents the positive result. (For inter-
pretation of the references to colour in this ﬁgure legend, the reader is referred to the
web version of this article.)
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conﬁned to the cell membrane in the parts of the epithelium
crossing the basement membrane and invading towards themesenchymal compartment of the 3D-OT (Fig. 3C, red arrows). Of
note, E-cadherin expression was stronger in DOKLuc from nDP
scaffolds (Fig. 3C, blue arrows), while showing weaker expression
and even negative areas DOKLuc from nDP-PHY scaffolds (Fig. 3C,
black arrows).
3.4. DOKLuc cells cultured on nDP scaffolds displayed reduced
tumorigenic potential in NSG mice compared to DOKLuc cells
cultured on other scaffolds
The total photon intensity of CL scaffolds xenotransplanted with
DOKLuc þ CAF was signiﬁcantly higher than of DOKLuc alone
throughout the 14 weeks of in vivo imaging (Fig. 4). The positive
control (DOKLuc þ CAF) in the nDP scaffolds also showed higher BLI
compared to nDP scaffolds with DOKLuc alone, but up to 8 weeks
only. After 8 weeks, the photon counts decreased to values com-
parable to those of xenografts formed by DOKLuc alone (Fig. 4). On
the contrary, the total photon count from nDP-PHY scaffolds car-
rying DOKLuc þ CAF had a signiﬁcantly higher intensity compared
to nDP-PHY scaffolds carrying DOKLuc alone that increased gradu-
ally throughout the 14 weeks of imaging. The tumours formed by
the scaffolds carrying DOKLuc þ CAF were also microscopically
examined and the pattern of invasion in the tumour front was
classiﬁed [43]. Generally, the xenotransplants showed a polarised
histological picture with proliferating cells at the periphery and
more differentiated areas, including keratin pearls, towards the
centre of the scaffold. The nDP-PHY scaffold had the highest
number of invasive tumours outside the scaffold area (100%)
(Fig. 5B). The pattern of invasion was mostly as small groups or
cords of inﬁltrating cells (>15) (Fig. 5, blue arrows). The lowest
number of invasive tumours over the limits of the scaffold area was
in the nDP scaffold groupwith only 2/6 xenografts showing signs of
invasion, although the pattern of invasion, when present, was
similar to the one seen in nDP-PHY scaffolds (Fig. 5, blue arrows).
All xenografts formed by (various scaffolds carrying DOKLuc alone)
displayed proliferating DOKLuc well conﬁned to the scaffolds' area.
The scaffold was mostly ﬁlled with ﬁbrous tissue (Fig. 5, black ar-
rows) and differentiated keratin pearls. When the involucrin stain
was carried out in these xenografts, modiﬁed scaffolds showed a
higher trend of expression compared to CL scaffolds (Fig. 5 C),
although not statistically signiﬁcant.
4. Discussion
This study evaluated the tumorigenic potential of functionalis-
ing poly(LLA-co-CL) scaffolds in vitro, in addition to using a recently
developed in vivo non-invasive environmentally-induced oral
carcinogenesis model.
Due to the adherent nature of DOK cells, not many cells could be
retrieved after typsinization of scaffolds, therefore a propagation
period was necessary in order to get enough number of cells to
carry out the functional tumorigenicity assays. Measurable differ-
ences when using several functional assays after the propagation
period could be seen with signiﬁcant differences between cells
grown on the different scaffolds, despite the propagation in culture
after the culture on scaffolds.
The DOKLuc previously seeded on nDP scaffolds after being
extracted, contained cells with a larger surface areamicroscopically
indicating a more differentiated phenotype for DOKLuc seeded on
these scaffolds. This is consistent with previous reports that pro-
posed nanoparticle modiﬁcation of scaffold material surfaces as an
efﬁcient method to increase cell attachment, reducing migration
and thus promoting differentiation [28,44]. This seemed to be
related to the improvement in topography and nano-scale archi-
tecture which resembles closer the extracellular matrix and to the
Fig. 4. In vivomonitoring of tumour formation. (A) Bioluminescence images from even weeks where a representative mouse from each scaffold group is displayed. Two scaffolds
were implanted into each mouse, one xenotransplanted with DOKLuc alone (negative control) (lower banner) and another with DOKLuc þ CAF (positive control) (upper banner)
(n ¼ 6). (B) Total photon count y axis¼ (photons  105/mm2/sec) from in vivo imaging of mice carrying different scaffolds xenotransplanted with negative and positive control
throughout 14 weeks of imaging. Data presented as mean ± SEM. *p < 0.05, **<0.01.
S. Suliman et al. / Biomaterials 95 (2016) 11e2118functional charged terminal groups present in nDP [28]. A recent
study using lactate dehydrogenase test on poly (lactic-co-glycolic
acid) membranes modiﬁed with nDP, reported no signiﬁcant dif-
ference in cytotoxicity of mesenchymal stem cells (MSC) for up to 9
days compared to unmodiﬁed membranes [44]. Another study on
osteoblasts found that the cells exhibited poorer proliferation but
signiﬁcantly improved long-term functions such as differentiation
markers when cultured on nanocrystalline diamond surfaces
compared to counterpart tested materials due to appropriate
nanotopography [45].
The result of the non-adherent culture that showed the highest
number of spheres were found to be from DOKLuc previously
seeded on nDP-PHY scaffolds is in line with a recent study that
proved that BMP-2-treated colon cancer cells formed spheres that
displayed signiﬁcantly elevated expression of stemness markers via
STAT3 transcription factor [46].
The DOKLuc previously grown on nDP scaffolds displayed a less
abnormal proliferation pattern in 3D-OT models when compared
with DOKLuc previously grown on other scaffolds. In a normal oral
epithelium, the basal and para-basal layer is the only proliferative
compartment, the rest of the epithelial layers display maturation
without any proliferative activity. Increased cell proliferation, and
particularly the abnormal presence of proliferating cells in the
supra-basal layers is a feature of transition to dysplasia and to
malignancy [47]. Thus, proliferation observed in supra-basal areasin certain conditions as that signiﬁcantly seen in nDP-PHY scaffold
as well the positive control raises concern on the carcinogenic
potential of that particular condition that should be taken with
caution. The cells from the nDP and CL scaffolds showed cell pro-
liferation more towards the normal distribution of proliferating
cells in oral epithelium, conﬁned to the basal layer. A previous study
that used Ki-67 in assessing the severity of epithelial dysplasia
demonstrated that the supra-basal expression provides an inde-
pendent criteria for determining the severity and histological
grading of OSCC [48]. These results emphasise the role nano-
diamonds might play in suppressing a dysplastic or abnormal
epithelial phenotype, thus pinpointing their potential for reducing
the tumorigenic risk. In a similar 3D-OT model, a comparable
pattern of Ki-67 staining equally distributed throughout all
epithelial layers was also noted when neoplastic human oral ker-
atinocytes (PE/CA-PJ 15 cell line) were cultured on top of the
collagenwith ﬁbroblasts which, based on other parameters as well,
were shown to represent a late stage oral carcinogenesis [49]. The
high expression of Ki-67 in nDP-PHY can be attributed to the BMP-
2, its enhancement effects on proliferation being reported previ-
ously, such as in ovarian cancer cells [50]. The reduced proliferation
seen in nDP modiﬁed scaffold group can be also considered a check
point to reduce errors accompanied with proliferation. However,
there are reports showing that incubating embryonic stem cells
with nanodiamonds led to mild DNA damage, particularly when
Fig. 5. Histology of the different scaffolds carrying DOKLuc or DOKLuc þ CAF after 14 weeks in vivo. (A) H&E sections showing histology of the different scaffolds carrying DOKLuc
or DOKLuc þ CAF after 14 weeks in vivo. First uppermost panel shows DOKLuc alone, scale bar ¼ 500 mm. Middle panel shows DOKLuc þ CAF, scale bar ¼ 500 mm. Lowest panel shows
invasion patterns in DOKLuc þ CAF, scale bar ¼ 200 mm. (B) Incidence of invasion from tumours formed in scaffolds carrying DOKLuc þ CAF (C) Quantiﬁcation of the involucrin
staining expressed as percentage of highly positive pixels showing higher differentiation trend in the nDP modiﬁed scaffolds, although not signiﬁcant. Error bars represent SEM.
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teins. The authors alleged that this damage was much less severe
than that caused by carbon nanotubes and it was probably attrib-
uted to reactive oxygen species [51]. The enhanced tumorigenic
potential in the DOKLuc could be due to BMP-2 or cross talk with
excretory molecules from CAF, leading to the reduced differentia-
tion and promoted proliferation as shown in Fig. 2 for those
respective conditions. The involucrin results corroborate well with
the Ki-67 results, in line with a similar study comparing different
scaffolds used to construct organotypics of oral mucosa, which alsoreported variable degrees and patterns of maturation or stratiﬁ-
cation in the epithelium as detected by immunohistochemistry,
depending on the scaffold used [52]. This demonstrates that the
topography of artiﬁcial extracellular matrices plays a role in the fate
of the cultured cells. Epithelial growth factor receptor (EGFR) is a
tyrosine kinase receptor highly expressed in several solid tumours,
including oral cancers and is related with increased proliferation,
invasion and poor prognosis of OSCC [53,54]. The pattern of EGFR
staining observed in our 3D-OT, although not signiﬁcant, showed
an opposite trend to the involucrin stain.
S. Suliman et al. / Biomaterials 95 (2016) 11e2120The DOKLuc cells previously grown on nDP scaffolds displayed
lower invasive potential in 3D-OT when compared to DOKLuc pre-
viously grown on other scaffolds. Tissue invasion is one of the ac-
quired hallmarks of cancer cells [55]. In a recent study evaluating
the effect of BMP-2 on the invasive capacity of OSCC cell lines, the
authors also used a co-culture model taking advantage of different
cells interacting in cancer and demonstrated how invasion could
not be evaluated when the cancer cells were in monoculture. This
underlines the role of stromal ﬁbroblasts or cancer microenviron-
ment [41,49]. Similar to our ﬁndings, rhBMP-2-treated humanOSCC
cell lines were found to show enhanced invasiveness and this was
dependent on the baseline mRNA expression of BMP-2 in these
cells [12]. Other cancer cell lines, such as colon cancer were also
found to have enhanced migratory and invasive potentials in
response to BMP-2 by induced epithelial-mesenchymal transition
(EMT) and downregulated E-cadherin [46]. This should not be
surprising, since a normal physiological EMT-promoting effect
during development and wound repair is known to be played by
BMPs [16,56]. A similar morphology of the expanded intercellular
spaces along the length of the epithelium to that seen in DOKLuc
grown on collagen biomatrices populated with CAF was previously
reported in oral mucosa constructs made with an established OSCC
cell line (PE/CA-PJ) [49]. This loss of intercellular adherence has
been for long considered a characteristic associated to oral
epithelial atypia in patient tissue samples [57]. However, the sig-
niﬁcant decrease in the DOKLuc invasion was observed in the 3D-
OTs that were seeded with DOKLuc from nDP scaffold highlights the
role played by the nDP in reducing the tumorigenic potential of
DOKLuc. DOKLuc cells previously grown on nDP scaffolds displayed
increased expression of cell adhesion molecule E-cadherin when
compared to DOKLuc previously grown on other scaffolds. This
pattern of staining is in accordance to the histomorphometric
measurements for quantifying the invasive potential (Fig. 3B).
To date, there are limited reports evaluating the carcinogenicity
of nanodiamond particles in vivo. The genotoxicity and nuclear
activity tests accompanied with oxidative stress reported in some
cell lines [58], do not give a fully functional dimension. Our recently
developed tumorigenicity in vivo model using BLI showed suc-
cessful application for screening functionalised copolymer scaffolds
intended for BTE (Fig. 4A and B). The total photon intensity of CL
scaffolds xenotransplanted with DOKLuc þ CAF was in line with the
recently published report [33]. The reduced intensity observed in
the positive control (DOKLuc þ CAF) in the nDP modiﬁed scaffolds
from 8weeks could be due to the nanodiamondmodiﬁcation of the
scaffold that might play a role in differentiating the tumours and
reducing their growth. The fact that the xenografts formed by nDP-
PHY scaffolds carrying DOKLuc þ CAF did not show a reduction in
the BLI as observed in the nDP scaffolds can be attributed to the
BMP-2 physisorbed onto the scaffolds and it is in accordance to the
in vitro results of sphere formation and 3D-OT assays. The higher
number of invasive tumours observed from the nDP-PHY scaffold
group is in linewith a previous study in an orthotopic mousemodel
which showed that xenografts from rhBMP-2-pre-treated OSSC cell
lines formed tumours with more rapid growth compared to control
and exhibited poorly differentiated morphology with poorer sur-
vival rate [11]. The potential role of BMP-2 in malignant trans-
formation and progression of cancer is still poorly understood
despite numerous reported studies. Some reports have shown re-
sults of BMP-2with a tumour suppressing effect in sarcomas, which
is in contrary to what studies in OSCC have reported. A study done
on a canine osteosarcoma model showed that the treatment using
the combination of stem cells from canine bonemarrow and BMP-2
was beneﬁcial for the host and could emerge as a potential thera-
peutic tool for osteosarcoma [59]. The effect of BMP-2 might
depend on the tumour type, but several other studies have alsosuggested a tumour suppressor effect from BMP-2 signalling that
inhibit proliferation and growth of colorectal cancer cells and os-
teosarcoma [60,61], so the issue is still a matter of debate. Addi-
tionally, the xenografts carrying DOKLuc alone in all groups showed
proliferating cells conﬁned to the scaffold area explaining the
constant low photon intensities in the negative controls. The nDP
modiﬁed scaffolds expressed higher trend of involucrin stain, in
line with the in vitro results.
5. Conclusions
Taken together, the results presented in this study demon-
strated that nDP modiﬁed copolymer scaffolds decreased the
tumorigenic potential of DOKLuc as shown by their reduced inva-
siveness, promoted differentiation and reduced adherence-
independent growth in vitro. These nDP modiﬁed scaffolds were
observed to reduce the size of tumours formed by DOKLuc þ CAF
in vivo as observed by BLI. This effect of nDP on tumorigenicity
encourages in-depth studies on the mechanism behind it to sup-
port their use in anti-cancer drug delivery after tumour resection.
The therapeutic use of BMP-2 should be cautioned in reconstruc-
tion of bone defects in oral cancer patients and further in-
vestigations on the bipolar effects of BMP-2 on tumorigenesis are
warranted.
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